Treatment with two potent inhibitors of TMEM16A, niclosamide and benzbromarone, significantly reduced renal cyst size in Pkd1−/− mice compared to control mice (Cabrita et al., 2020). This evidence concerns the gene ANO1 and cystic kidney disease.